Decreased vasomotor effect of endothelin on the coronary arteries during angioplasty in hypertensive patients

International Journal of Cardiology

Volumn 55, Issue 1, 1996, Pages 41-48

  Kyriakides, Zenon S ^a   Markianos, Manolis ^b   Paraskevaidis, Ioannis A ^a   Tousoulis, Dimitrios ^a   Fragakis, Nikolaos K ^c   Kremastinos, Dimitrios Th ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Coronary angioplasty; Coronary artery reactivity; Endothelin 1; Systemic hypertension

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN 1; GLYCERYL TRINITRATE; HEPARIN; NITRIC ACID DERIVATIVE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PRIORITY JOURNAL; SUBLINGUAL DRUG ADMINISTRATION; TRANSLUMINAL CORONARY ANGIOPLASTY; VASOMOTOR REFLEX;

EID: 0030570405     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02653-8     Document Type: Article

References (30)

1. [1] Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
2. [2] Tahara A, Kohno M, Yanagi S, et al. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal angioplasty. Metabolism 1991; 40: 1235-1237.
3. [3] Kyriakides ZS, Markianos M, Iliodromitis EK, Kremastinos DT. Vein plasma endothelin-1 and cyclic GMP increase during coronary angioplasty is related to myocardial ischemia. Eur Heart J 1995; 16; 894-898.
4. [4] Schiffrin EL, Deng LY, Larochelle P. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertension patients. J Hypertens 1992; 10: 437-444.
5. [5] Luscher TF. Endothelin. J Cardiovasc Pharmacol 1991; 18 Suppl 10: S15-S22.
6. [6] Luscher TF, Dohi Y, Tschudi M. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J Cardiovasc Pharmacol 1992; 19 Suppl 5: S34-S42.
7. [7] Kyriakides ZS, Markianos M, Iliodromitis E, Tsiapras D, Fragakis N, Kremastinos DTh. Peripheral vein plasma endothelin-1 levels during coronary angioplasty increase only in normotensive patients. Cardiovasc Drugs Ther 1994; 8: 775-777.
8. [8] Kyriakides ZS, Tousoulis D, Iliodromitis E, Apostolou T, Michelakakis N, Kremastinos DTh. The reactivity of the contralateral artery at the time of balloon dilation during coronary angioplasty. Eur Heart J 1995; 16: 794-798.
9. [9] Kyriakides MK, Petropoulakis PN, Tentolouris CA, et al. Relation between changes in blood flow of the contralateral coronary artery and the angiographic extent and function of recruitable collateral vessels arising from this artery during balloon occlusion. J Am Coll Cardiol 1994; 23: 869-878.
10. [10] Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography: American Society of Echocardiography Committee on Standards Subcommittee. J Am Soc Echo 1989; 2: 358-367.
11. [11] Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 1991; 84 (Suppl 1): I-280-I-287.
12. [12] Cohen M, Rentrop P. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986; 74: 469-476.
13. [13] Reiber JHC, Serruys PW, Koouman C, et al. Assessment of short-, medium- and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985; 71: 280-288.
14. [14] Austen WG, Edwards JE, Frye RL, et al. Reporting system on patients vaulted for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease, council on cardiovascular surgery, American Heart Association. Circulation 1975; 51: 7-37.
15. [15] Ryan TJ, Vekshstein VI, Yeung AC, Bittl JA, Selwyn AP, Ganz P. The role of endothelin-1 in coronary vasoconstriction following balloon angioplasty. (Abstract). Eur Heart J 1991; 12: 160.
16. [16] Estrada V, Fernandez-Durango R, Moya JJ, et al. Endothelin-1 in unstable angina before and after coronary angioplasty. (Abstract). Eur Heart J 1991; 12: 161.
17. [17] Tonnessen T, Naess PA, Kirkeboen KA, Offstad J, Ilebekk A, Christensen G. Release of endothelin from the porcine heart after short term coronary artery occlusion. Cardiovasc Res 1993; 27: 1482-1485.
18. [18] Tomoda H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J 1993; 12: 667-672.
19. [19] Yasuda M, Kohno M, Tahara A, et al. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J 1990; 119: 801-806.
20. [20] Rubanyi GM, Vanhoutte PM. Hypoxia release a vasoconstrictor substance from the canine vascular endothelium. J Physiol 1985; 364: 45-56.
21. [21] Tonnessen T, Naess PA, Kirkeboen KA, Offstad J, Ilebekk A, Christensen G. Endothelin is released from the porcine coronary circulation after short-term ischemia. J Cardiovasc Pharmacol 1993; 22 Suppl 8: S313-S316.
22. [22] Barone FC, Globus MY, Price WJ, et al. Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab 1994; 14: 337-332.
23. [23] Simonetti I, Caterina R, Michelassi C, Marzilli M, DeNes M, L'Abbate A. Coronary vasodilation by nitrates is not mediated by the prostaglandin system: a quantitative cineangiographic study. J Am Coll Cardiol 1986; 8: 1263-1270.
24. [24] Tousoulis D, Kaski JC, Bogaty P, et al. Reactivity of proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina pectoris. Am J Cardiol 1991; 67: 1195-1200.
25. [25] Kyriakides ZS, Kremastinos DT, Michelakakis NA, Matsakas EP, Demovelis T, Toutouzas PK. Coronary collateral circulation in coronary artery disease and systemic hypertension. Am J Cardiol 1991; 67: 687-690.
26. [26] Kyriakides ZS, Sbarouni E, Paraskevaidis I, Karavolias G, Kremastinos DTh. Coronary collateral circulation is augmented in patients with coronary artery disease and systemic hypertension. Evaluation by intraarterial pressure measurement. (Abstract) Eur Heart J 1994; 15: 288.
27. [27] Miyauchi T, Yanagisawa M, Lida K, et al. Age-and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am Heart J 1992; 123: 1092-1093.
28. [28] Saito Y, Nakao K, Mukoyama M, Imura H. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990; 332: 205.
29. [29] Tschudi MR, Luscher TF. Divergent effects of ageing and hypertension on contractions to endothelin-1 and serotonin in rat coronary arteries. (Abstract) Eur Heart J 1994; 15: 84.
30. [30] Yang Z, Richard V, Segesser LV, et al. Threshold concentrations of endothelin-1 potentiate contractions to norepi-nephrine and serotonin in human arteries. A new mechanism of vasospasm. Circulation 1990; 82: 188-195.